2Hansson L.Beta-blakers in hypertension[J].J Hypertens,1987,5[Suppl 3]:S61.
3No authors listed.The 1988 report of the Joint National Committee.Detection,evaluation and treatment of high blood pressure[J].Arch Intern Med,1988,148(5):1023-1038.
4No authors listed.The fifth report of the Joint National Committee on Detection,Evaluation and Treatment of High Blood Pressure(JNC V)[J].Arch Intern Med,1993,153(2):154-183.
5No authors listed.The guidelines subcommittee of the WHO／ISH mild hypertension liaison committee,1993 guidelines for the management of mild hypertension:memorandum from a World Health Organization／International Society of Hypertension Meeeting[J].Hypertension,1993,22(4):392.
6Psaty BM, Smith NS, Siscovick DS, et al. Healthy outcome associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis[J] .JAMA, 1997,277(2) :739-745.
7Freis ED. The efficacy and safety of diuretics in treating hypertension[J] .Ann Intern Med, 1995,122(3):223-226.
8Kennedy HL. Current utilization trends for beta-blockers in cardiovascular disease[J] .Am J Med,2001,110[ Snppl] :5-6.
9Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arterties in hypertension : role of adhersion molecules and extracellular matrix determinants[J]. Hupertension,2000,36(3):312-318.
